Stocks in Action USA: ADMA Biologics, Tesla, and Boeing.

ADMA Biologics (ADMA) – The stock of the biotech company reaches a 52-week high after FDA approval! The shares of ADMA Biologics soared by 15% to $25.25 on April 28, reaching a new 52-week high of $25.67 during the day. This continues the impressive performance of the stock. The recent price surge was triggered by the approval of an innovative manufacturing process by the US Food and Drug Administration (FDA), which can increase the yield in the production of immunoglobulin products by about 20% while maintaining the same starting plasma material....